A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 27 shares of VRTX stock, worth $10,726. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 27 -0.0%
Holding current value
$10,726
Previous $12,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$392.81 - $485.53 $4,320 - $5,340
11 Added 68.75%
27 $12,000
Q1 2024

May 06, 2024

SELL
$407.69 - $446.08 $407 - $446
-1 Reduced 5.88%
16 $6,000
Q4 2023

May 06, 2024

BUY
$343.0 - $410.68 $343 - $410
1 Added 6.25%
17 $6.92 Million
Q4 2023

Feb 05, 2024

BUY
$343.0 - $410.68 $5,831 - $6,981
17 New
17 $6.92 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $102B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Di Nuzzo Private Wealth, Inc. Portfolio

Follow Di Nuzzo Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Di Nuzzo Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Di Nuzzo Private Wealth, Inc. with notifications on news.